FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3188989920> ?p ?o ?g. }

• W3188989920 endingPage "364" @default.
• W3188989920 startingPage "356" @default.
• W3188989920 abstract "Objective To assess the prevalence and potential risk factors for polypharmacy and prescribing of the potentially inappropriate medications, opioids and benzodiazepines/Z‐drugs, in older adults with systemic lupus erythematosus (SLE). Methods The study population comprised adults age ≥50 years meeting American College of Rheumatology or Systemic Lupus International Collaborating Clinics classification criteria followed at a tertiary care rheumatology clinic. Information on prescriptions filled in the 4 months preceding chart review was obtained from the Manitoba Drug Program Information Network. Clinical data, including age, sex, Charlson Comorbidity Index (CCI) score, Systemic Lupus Erythematosus Disease Activity Index 2000 score, prednisone use, SLE duration, and rural residence were abstracted from electronic medical records. Logistic regression analyses were performed to assess any association between polypharmacy (using 2 definitions: ≥5 and ≥10 medications), potentially inappropriate medication use, and clinical features. Results A total of 206 patients (mean age 62 years, 91% female, 36% rural) were included: 148 (72%) filled ≥5 medications, 71 (35%) filled ≥10 medications, 63 (31%) used benzodiazepines/Z‐drugs, and 50 (24%) used opioids. Among the 77 patients age ≥65 years, 57 (74%) filled ≥5 medications, and 26 (34%) filled ≥10 medications, compared to 30% and 4%, respectively, of Manitobans age ≥65 years (National Prescription Drug Utilization Information System, 2016). The odds of polypharmacy were greater with prednisone use (adjusted odds ratio [OR] 3.70 [95% confidence interval (95% CI) 1.40–9.79] for ≥5 medications), CCI score (adjusted OR 1.62 [95% CI 1.20–2.17]), and rural residence (adjusted OR 2.05 [95% CI 1.01–4.18]). Odds of benzodiazepine/Z‐drug use were increased with polypharmacy (adjusted OR 4.35 [95% CI 1.69–11.22]), and odds of opioid use were increased with polypharmacy (adjusted OR 6.75 [95% CI 1.93–23.69]) and CCI score (adjusted OR 1.29 [95% CI 1.08–1.54]). Conclusion The prevalence of polypharmacy in this SLE cohort was higher than in the general Manitoban population. Polypharmacy is a strong marker for use of prescription benzodiazepines/Z‐drugs and opioids." @default.
• W3188989920 created "2021-08-16" @default.
• W3188989920 creator A5036050193 @default.
• W3188989920 creator A5042007343 @default.
• W3188989920 creator A5049178019 @default.
• W3188989920 creator A5071536652 @default.
• W3188989920 creator A5088577091 @default.
• W3188989920 creator A5088961292 @default.
• W3188989920 date "2022-10-11" @default.
• W3188989920 modified "2023-10-17" @default.
• W3188989920 title "Polypharmacy and Potentially Inappropriate Medication Use in Older Adults With Systemic Lupus Erythematosus" @default.
• W3188989920 cites W1482945777 @default.
• W3188989920 cites W1736805871 @default.
• W3188989920 cites W1749419663 @default.
• W3188989920 cites W1972148020 @default.
• W3188989920 cites W1986689424 @default.
• W3188989920 cites W2000445173 @default.
• W3188989920 cites W2031367983 @default.
• W3188989920 cites W2063055176 @default.
• W3188989920 cites W2074906549 @default.
• W3188989920 cites W2120365383 @default.
• W3188989920 cites W2342223040 @default.
• W3188989920 cites W2429408914 @default.
• W3188989920 cites W2547178450 @default.
• W3188989920 cites W2575131381 @default.
• W3188989920 cites W2611842004 @default.
• W3188989920 cites W2763920048 @default.
• W3188989920 cites W2767602096 @default.
• W3188989920 cites W2768427638 @default.
• W3188989920 cites W2776828305 @default.
• W3188989920 cites W2790083419 @default.
• W3188989920 cites W2800087105 @default.
• W3188989920 cites W2810797036 @default.
• W3188989920 cites W2883869784 @default.
• W3188989920 cites W2889191686 @default.
• W3188989920 cites W2896592517 @default.
• W3188989920 cites W2899351576 @default.
• W3188989920 cites W2901279013 @default.
• W3188989920 cites W2905717169 @default.
• W3188989920 cites W2911606226 @default.
• W3188989920 cites W2936737119 @default.
• W3188989920 cites W2939663188 @default.
• W3188989920 cites W2940630198 @default.
• W3188989920 cites W2946256512 @default.
• W3188989920 cites W2949704083 @default.
• W3188989920 cites W295990780 @default.
• W3188989920 cites W2965078445 @default.
• W3188989920 cites W2975447004 @default.
• W3188989920 cites W3000108621 @default.
• W3188989920 cites W3088819378 @default.
• W3188989920 doi "https://doi.org/10.1002/acr.24766" @default.
• W3188989920 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34369087" @default.
• W3188989920 hasPublicationYear "2022" @default.
• W3188989920 type Work @default.
• W3188989920 sameAs 3188989920 @default.
• W3188989920 citedByCount "2" @default.
• W3188989920 countsByYear W31889899202022 @default.
• W3188989920 crossrefType "journal-article" @default.
• W3188989920 hasAuthorship W3188989920A5036050193 @default.
• W3188989920 hasAuthorship W3188989920A5042007343 @default.
• W3188989920 hasAuthorship W3188989920A5049178019 @default.
• W3188989920 hasAuthorship W3188989920A5071536652 @default.
• W3188989920 hasAuthorship W3188989920A5088577091 @default.
• W3188989920 hasAuthorship W3188989920A5088961292 @default.
• W3188989920 hasConcept C126322002 @default.
• W3188989920 hasConcept C156957248 @default.
• W3188989920 hasConcept C195910791 @default.
• W3188989920 hasConcept C198451711 @default.
• W3188989920 hasConcept C2426938 @default.
• W3188989920 hasConcept C2776912625 @default.
• W3188989920 hasConcept C2778720950 @default.
• W3188989920 hasConcept C2779134260 @default.
• W3188989920 hasConcept C2779159551 @default.
• W3188989920 hasConcept C2908647359 @default.
• W3188989920 hasConcept C36434225 @default.
• W3188989920 hasConcept C44249647 @default.
• W3188989920 hasConcept C71924100 @default.
• W3188989920 hasConcept C98274493 @default.
• W3188989920 hasConcept C99454951 @default.
• W3188989920 hasConceptScore W3188989920C126322002 @default.
• W3188989920 hasConceptScore W3188989920C156957248 @default.
• W3188989920 hasConceptScore W3188989920C195910791 @default.
• W3188989920 hasConceptScore W3188989920C198451711 @default.
• W3188989920 hasConceptScore W3188989920C2426938 @default.
• W3188989920 hasConceptScore W3188989920C2776912625 @default.
• W3188989920 hasConceptScore W3188989920C2778720950 @default.
• W3188989920 hasConceptScore W3188989920C2779134260 @default.
• W3188989920 hasConceptScore W3188989920C2779159551 @default.
• W3188989920 hasConceptScore W3188989920C2908647359 @default.
• W3188989920 hasConceptScore W3188989920C36434225 @default.
• W3188989920 hasConceptScore W3188989920C44249647 @default.
• W3188989920 hasConceptScore W3188989920C71924100 @default.
• W3188989920 hasConceptScore W3188989920C98274493 @default.
• W3188989920 hasConceptScore W3188989920C99454951 @default.
• W3188989920 hasIssue "2" @default.
• W3188989920 hasLocation W31889899201 @default.
• W3188989920 hasLocation W31889899202 @default.
• W3188989920 hasOpenAccess W3188989920 @default.

• next